Pulmonologists in Japan reported a median annual income of ¥15 million (approximately £72,000) in the latest specialty-level physician income survey from the Physician Career Research Institute. The 2025 survey, based on responses from 2,055 physicians overall, provides a useful benchmark for pulmonologists assessing their professional earnings in Japan. Among the Pulmonology respondents: Median annual income: ¥15 million (approximately £72,000) Proportion earning ¥20 million or more: 16.67% ¥20 million threshold: approximately £96,000 Pulmonology respondents: 48 Importantly, these figures include income from a pulmonologist’s main workplace as well as additional or side work. For pulmonologists looking at their own compensation, that distinction is essential. What is the median income for a pulmonologist in Japan? The reported median annual income for pulmonologists was: ¥15 million (approximately £72,000) This represents total annual professional income including side work, rather than simply the salary paid by a pulmonologist’s principal hospital, clinic or other employer. That matters because physicians in Japan may receive income from more than one professional role. A pulmonologist may hold a primary hospital or clinic position while also undertaking additional clinical sessions or other paid medical work. The ¥15 million figure is therefore best understood as a benchmark for total annual professional earnings. It should not be interpreted as an expected base salary. 16.67% of pulmonologists reported earning ¥20 million or more The survey provides another useful benchmark for pulmonologists. 16.67% of Pulmonology respondents reported annual income of ¥20 million or more (approximately £96,000+). That means roughly one in six pulmonologists included in the survey reported total annual professional earnings at or above this level. For a pulmonologist assessing their own compensation, the two central figures are therefore: Median annual income: ¥15 million (approximately £72,000) Earning ¥20 million+ (approximately £96,000+): 16.67% Together, these figures provide a useful indication of the income levels reported within Pulmonology. Why does side work matter for pulmonologist income? Additional professional work can form an important part of physician earnings in Japan. Doctors may undertake paid work outside their main position, including sessions at other hospitals or clinics and other secondary medical activity. The Physician Career Research Institute therefore reports annual income including side work. For pulmonologists, this means that salary from the principal employer may not represent total annual earnings. A pulmonologist whose main salary is below ¥15 million could still reach or exceed the survey benchmark when supplementary clinical income is included. Equally, the survey should not be interpreted as showing that pulmonologists should expect a ¥15 million basic salary from a single employer. The figure represents a broader measure of total professional income. What does the ¥15 million median actually mean? There is an important methodological point behind the headline figure. Survey participants reported income in ranges rather than providing an exact annual amount. The reported median of ¥15 million (approximately £72,000) therefore represents the midpoint of the relevant income band. It should be treated as an approximate compensation benchmark rather than a precise mathematical median calculated from exact salary records. For a pulmonologist reviewing their own income, the figure is most useful as a broad reference point for total annual professional earnings. How strong is the Pulmonology sample? The wider survey included 2,055 physicians, with 48 respondents in Pulmonology. That gives pulmonology its own identifiable specialty sample within the research. However, it remains survey evidence rather than a national census of all pulmonologists working in Japan. Actual earnings may vary depending on factors such as: career stage; seniority; employer; hospital or clinic setting; working hours; geographic location; additional clinical commitments; and the amount of side work undertaken. For pulmonologists, the findings are therefore most useful as a current compensation benchmark rather than a guaranteed income level. Is ¥15 million a pulmonologist salary? No. The clearest interpretation is: ¥15 million is the reported median total annual professional income for the pulmonologists surveyed, including side work. It is not a published base salary. For a pulmonologist considering a new role or assessing existing compensation, it can therefore be useful to distinguish between: guaranteed income from the principal employer; additional paid clinical sessions; other professional income; and total annual earnings. The survey benchmark relates most closely to that final figure. What should pulmonologists take from the latest data? For pulmonologists in Japan, the 2025 survey provides two particularly useful compensation benchmarks. Median annual professional income, including side work, was: ¥15 million (approximately £72,000) And: 16.67% of pulmonologists reported earning ¥20 million or more (approximately £96,000+). For an individual pulmonologist, these figures provide a useful reference point when considering total annual professional earnings. The important point is to compare like with like. A salary from a single hospital or clinic should not be compared directly with a survey figure that incorporates additional professional work. For pulmonologists, the more useful question is therefore not simply: “What is a pulmonologist’s salary in Japan?” It is: “What is my total annual professional income as a pulmonologist, including additional clinical work, and how does it compare with the ¥15 million benchmark?” That is the most meaningful way to use the available Pulmonology compensation data. Source: Physician Career Research Institute / Mediwel, 2025 Physician Income Survey. Currency note: Sterling equivalents are approximate conversions using the JPY/GBP exchange rate on 14 September 2026. At that rate, ¥15 million is approximately £72,000 and ¥20 million approximately £96,000. GBP figures are included for reader context only and were not reported by the original Japanese survey. Discover how nuaxia can support your next medical education initiative: Find out more about our specialist services - Moore's Outcome Assessments, Educational Needs Assessments and Patient Impact Studies for the Medical Education sector Contact us on: support@nuaxia.com

Thoracic surgeons in Japan reported a median annual income of ¥17 million (approximately £82,000) in the latest specialty-level physician income survey from the Physician Career Research Institute. The 2025 survey, based on responses from 2,055 physicians overall, provides a useful benchmark for thoracic surgeons assessing their professional earnings in Japan. Among the Thoracic Surgery respondents: Median annual income: ¥17 million (approximately £82,000) Proportion earning ¥20 million or more: 17.65% ¥20 million threshold: approximately £96,000 Thoracic Surgery respondents: 17 Importantly, these figures include income from a thoracic surgeon’s main workplace as well as additional or side work. For thoracic surgeons looking at their own compensation, that distinction is essential. What is the median income for a thoracic surgeon in Japan? The reported median annual income for thoracic surgeons was: ¥17 million (approximately £82,000) This represents total annual professional income including side work, rather than simply the salary paid by a thoracic surgeon’s principal hospital or employer. That matters because physicians in Japan may receive income from more than one professional role. A thoracic surgeon may hold a primary hospital appointment while also undertaking additional clinical sessions, surgical work or other paid medical activity. The ¥17 million figure is therefore best understood as a benchmark for total annual professional earnings. It should not be interpreted as an expected base salary. 17.65% of thoracic surgeons reported earning ¥20 million or more The survey provides another useful benchmark for thoracic surgeons. 17.65% of Thoracic Surgery respondents reported annual income of ¥20 million or more (approximately £96,000+). That means just under one in five thoracic surgeons included in the survey reported total annual professional earnings at or above this level. For a thoracic surgeon assessing their own compensation, the two central figures are therefore: Median annual income: ¥17 million (approximately £82,000) Earning ¥20 million+ (approximately £96,000+): 17.65% Together, these figures provide a useful indication of the income levels reported within Thoracic Surgery. Why does side work matter for thoracic surgeon income? Additional professional work can form an important part of physician earnings in Japan. Doctors may undertake paid work outside their main position, including sessions at other hospitals or clinics and other secondary medical activity. The Physician Career Research Institute therefore reports annual income including side work. For thoracic surgeons, this means that salary from the principal employer may not represent total annual earnings. A thoracic surgeon whose main salary is below ¥17 million could still reach or exceed the survey benchmark when supplementary clinical income is included. Equally, the survey should not be interpreted as showing that thoracic surgeons should expect a ¥17 million basic salary from a single employer. The figure represents a broader measure of total professional income. What does the ¥17 million median actually mean? There is an important methodological point behind the headline figure. Survey participants reported income in ranges rather than providing an exact annual amount. The reported median of ¥17 million (approximately £82,000) therefore represents the midpoint of the relevant income band. It should be treated as an approximate compensation benchmark rather than a precise mathematical median calculated from exact salary records. For a thoracic surgeon reviewing their own income, the figure is most useful as a broad reference point for total annual professional earnings. How strong is the Thoracic Surgery sample? The wider survey included 2,055 physicians, with 17 respondents in Thoracic Surgery. That is an important limitation. The research only published specialty-level figures for groups with at least 15 respondents, so Thoracic Surgery met the threshold for inclusion. However, 17 physicians remains a small sample. The findings should therefore be treated as a useful specialty benchmark rather than a definitive national estimate for every thoracic surgeon working in Japan. Actual earnings may vary depending on factors such as: career stage; seniority; employer; hospital setting; surgical workload; working hours; geographic location; additional clinical commitments; and the amount of side work undertaken. Is ¥17 million a thoracic surgeon salary? No. The clearest interpretation is: ¥17 million is the reported median total annual professional income for the thoracic surgeons surveyed, including side work. It is not a published base salary. For a thoracic surgeon considering a new role or assessing existing compensation, it can therefore be useful to distinguish between: guaranteed income from the principal employer; additional paid surgical or clinical work; other professional income; and total annual earnings. The survey benchmark relates most closely to that final figure. What should thoracic surgeons take from the latest data? For thoracic surgeons in Japan, the 2025 survey provides two particularly useful compensation benchmarks. Median annual professional income, including side work, was: ¥17 million (approximately £82,000) And: 17.65% of thoracic surgeons reported earning ¥20 million or more (approximately £96,000+). For an individual thoracic surgeon, these figures provide a useful reference point when considering total annual professional earnings. The important point is to compare like with like. A salary from a single hospital should not be compared directly with a survey figure that incorporates additional professional work. For thoracic surgeons, the more useful question is therefore not simply: “What is a thoracic surgeon’s salary in Japan?” It is: “What is my total annual professional income as a thoracic surgeon, including additional clinical work, and how does it compare with the ¥17 million benchmark?” That is the most meaningful way to use the available Thoracic Surgery compensation data. Source: Physician Career Research Institute / Mediwel, 2025 Physician Income Survey. Currency note: Sterling equivalents are approximate conversions using the JPY/GBP exchange rate on 14 September 2026. At that rate, ¥17 million is approximately £82,000 and ¥20 million approximately £96,000. GBP figures are included for reader context only and were not reported by the original Japanese survey. Discover how nuaxia can support your next medical education initiative: Find out more about our specialist services - Moore's Outcome Assessments, Educational Needs Assessments and Patient Impact Studies for the Medical Education sector Contact us on: support@nuaxia.com

Pediatricians in Japan reported a median annual income of ¥15 million (approximately £72,000) in the latest specialty-level physician income survey from the Physician Career Research Institute. The 2025 survey, based on responses from 2,055 physicians overall, provides a useful benchmark for pediatricians assessing their professional earnings in Japan. Among the Pediatrics respondents: Median annual income: ¥15 million (approximately £72,000) Proportion earning ¥20 million or more: 19.77% ¥20 million threshold: approximately £96,000 Pediatrics respondents: 86 Importantly, these figures include income from a pediatrician’s main workplace as well as additional or side work. For pediatricians looking at their own compensation, that distinction is essential. What is the median income for a pediatrician in Japan? The reported median annual income for pediatricians was: ¥15 million (approximately £72,000) This represents total annual professional income including side work, rather than simply the salary paid by a pediatrician’s principal hospital, clinic or other employer. That matters because physicians in Japan may receive income from more than one professional role. A pediatrician may hold a primary hospital or clinic position while also undertaking additional clinical sessions, shifts or other paid medical work. The ¥15 million figure is therefore best understood as a benchmark for total annual professional earnings. It should not be interpreted as an expected base salary. 19.77% of pediatricians reported earning ¥20 million or more The survey provides another useful benchmark for pediatricians. 19.77% of Pediatrics respondents reported annual income of ¥20 million or more (approximately £96,000+). That means around one in five pediatricians included in the survey reported total annual professional earnings at or above this level. For a pediatrician assessing their own compensation, the two central figures are therefore: Median annual income: ¥15 million (approximately £72,000) Earning ¥20 million+ (approximately £96,000+): 19.77% Together, these figures provide a useful indication of the income levels reported within Pediatrics. Why does side work matter for pediatrician income? Additional professional work can form an important part of physician earnings in Japan. Doctors may undertake paid work outside their main position, including sessions at other hospitals or clinics and other secondary medical activity. The Physician Career Research Institute therefore reports annual income including side work. For pediatricians, this means that salary from the principal employer may not represent total annual earnings. A pediatrician whose main salary is below ¥15 million could still reach or exceed the survey benchmark when supplementary professional income is included. Equally, the survey should not be interpreted as showing that pediatricians should expect a ¥15 million basic salary from a single employer. The figure represents a broader measure of total professional income. What does the ¥15 million median actually mean? There is an important methodological point behind the headline figure. Survey participants reported income in ranges rather than providing an exact annual amount. The reported median of ¥15 million (approximately £72,000) therefore represents the midpoint of the relevant income band. It should be treated as an approximate compensation benchmark rather than a precise mathematical median calculated from exact salary records. For a pediatrician reviewing their own income, the figure is most useful as a broad reference point for total annual professional earnings. How strong is the Pediatrics sample? The wider survey included 2,055 physicians, with 86 respondents in Pediatrics. That gives pediatrics a useful specialty-specific sample within the research. However, it remains survey evidence rather than a national census of all pediatricians working in Japan. Actual earnings may vary depending on factors such as: career stage; seniority; employer; hospital or clinic setting; working hours; geographic location; additional clinical commitments; and the amount of side work undertaken. For pediatricians, the findings are therefore most useful as a current compensation benchmark rather than a guaranteed income level. Is ¥15 million a pediatrician salary? No. The clearest interpretation is: ¥15 million is the reported median total annual professional income for the pediatricians surveyed, including side work. It is not a published base salary. For a pediatrician considering a new role or assessing existing compensation, it can therefore be useful to distinguish between: guaranteed income from the principal employer; additional paid clinical sessions; other professional income; and total annual earnings. The survey benchmark relates most closely to that final figure. What should pediatricians take from the latest data? For pediatricians in Japan, the 2025 survey provides two particularly useful compensation benchmarks. Median annual professional income, including side work, was: ¥15 million (approximately £72,000) And: 19.77% of pediatricians reported earning ¥20 million or more (approximately £96,000+). For an individual pediatrician, these figures provide a useful reference point when considering total annual professional earnings. The important point is to compare like with like. A salary from a single hospital or clinic should not be compared directly with a survey figure that incorporates additional professional work. For pediatricians, the more useful question is therefore not simply: “What is a pediatrician’s salary in Japan?” It is: “What is my total annual professional income as a pediatrician, including additional clinical work, and how does it compare with the ¥15 million benchmark?” That is the most meaningful way to use the available Pediatrics compensation data. Source: Physician Career Research Institute / Mediwel, 2025 Physician Income Survey. Currency note: Sterling equivalents are approximate conversions using the JPY/GBP exchange rate on 14 September 2026. At that rate, ¥15 million is approximately £72,000 and ¥20 million approximately £96,000. GBP figures are included for reader context only and were not reported by the original Japanese survey. Discover how nuaxia can support your next medical education initiative: Find out more about our specialist services - Moore's Outcome Assessments, Educational Needs Assessments and Patient Impact Studies for the Medical Education sector Contact us on: support@nuaxia.com

Ophthalmologists in Japan reported a median annual income of ¥13 million (approximately £62,000) in the latest specialty-level physician income survey from the Physician Career Research Institute. The 2025 survey, based on responses from 2,055 physicians overall, provides a useful benchmark for ophthalmologists assessing their professional earnings in Japan. Among the Ophthalmology respondents: Median annual income: ¥13 million (approximately £62,000) Proportion earning ¥20 million or more: 20.69% ¥20 million threshold: approximately £96,000 Ophthalmology respondents: 58 Importantly, these figures include income from an ophthalmologist’s main workplace as well as additional or side work. For ophthalmologists looking at their own compensation, that distinction is essential. What is the median income for an ophthalmologist in Japan? The reported median annual income for ophthalmologists was: ¥13 million (approximately £62,000) This represents total annual professional income including side work, rather than simply the salary paid by an ophthalmologist’s principal hospital, clinic or other employer. That matters because physicians in Japan may receive income from more than one professional role. An ophthalmologist may hold a primary hospital or clinic position while also undertaking additional clinical sessions or other paid medical work. The ¥13 million figure is therefore best understood as a benchmark for total annual professional earnings. It should not be interpreted as an expected base salary. 20.69% of ophthalmologists reported earning ¥20 million or more The survey provides another useful benchmark for ophthalmologists. 20.69% of Ophthalmology respondents reported annual income of ¥20 million or more (approximately £96,000+). That means just over one in five ophthalmologists included in the survey reported total annual professional earnings at or above this level. For an ophthalmologist assessing their own compensation, the two central figures are therefore: Median annual income: ¥13 million (approximately £62,000) Earning ¥20 million+ (approximately £96,000+): 20.69% Together, these figures provide a useful indication of the income levels reported within Ophthalmology. Why does side work matter for ophthalmologist income? Additional professional work can form an important part of physician earnings in Japan. Doctors may undertake paid work outside their main position, including sessions at other hospitals or clinics and other secondary medical activity. The Physician Career Research Institute therefore reports annual income including side work. For ophthalmologists, this means that salary from the principal employer may not represent total annual earnings. An ophthalmologist whose main salary is below ¥13 million could still reach or exceed the survey benchmark when supplementary clinical income is included. Equally, the survey should not be interpreted as showing that ophthalmologists should expect a ¥13 million basic salary from a single employer. The figure represents a broader measure of total professional income. What does the ¥13 million median actually mean? There is an important methodological point behind the headline figure. Survey participants reported income in ranges rather than providing an exact annual amount. The reported median of ¥13 million (approximately £62,000) therefore represents the midpoint of the relevant income band. It should be treated as an approximate compensation benchmark rather than a precise mathematical median calculated from exact salary records. For an ophthalmologist reviewing their own income, the figure is most useful as a broad reference point for total annual professional earnings. How strong is the Ophthalmology sample? The wider survey included 2,055 physicians, with 58 respondents in Ophthalmology. That gives ophthalmology a useful specialty-specific sample within the research. However, it remains survey evidence rather than a national census of all ophthalmologists working in Japan. Actual earnings may vary depending on factors such as: career stage; seniority; employer; hospital or clinic setting; working hours; geographic location; additional clinical commitments; and the amount of side work undertaken. For ophthalmologists, the findings are therefore most useful as a current compensation benchmark rather than a guaranteed income level. Is ¥13 million an ophthalmologist salary? No. The clearest interpretation is: ¥13 million is the reported median total annual professional income for the ophthalmologists surveyed, including side work. It is not a published base salary. For an ophthalmologist considering a new role or assessing existing compensation, it can therefore be useful to distinguish between: guaranteed income from the principal employer; additional paid clinical sessions; other professional income; and total annual earnings. The survey benchmark relates most closely to that final figure. What should ophthalmologists take from the latest data? For ophthalmologists in Japan, the 2025 survey provides two particularly useful compensation benchmarks. Median annual professional income, including side work, was: ¥13 million (approximately £62,000) And: 20.69% of ophthalmologists reported earning ¥20 million or more (approximately £96,000+). For an individual ophthalmologist, these figures provide a useful reference point when considering total annual professional earnings. The important point is to compare like with like. A salary from a single hospital or clinic should not be compared directly with a survey figure that incorporates additional professional work. For ophthalmologists, the more useful question is therefore not simply: “What is an ophthalmologist’s salary in Japan?” It is: “What is my total annual professional income as an ophthalmologist, including additional clinical work, and how does it compare with the ¥13 million benchmark?” That is the most meaningful way to use the available Ophthalmology compensation data. Source: Physician Career Research Institute / Mediwel, 2025 Physician Income Survey. Currency note: Sterling equivalents are approximate conversions using the JPY/GBP exchange rate on 14 September 2026. At that rate, ¥13 million is approximately £62,000 and ¥20 million approximately £96,000. GBP figures are included for reader context only and were not reported by the original Japanese survey. Discover how nuaxia can support your next medical education initiative: Find out more about our specialist services - Moore's Outcome Assessments, Educational Needs Assessments and Patient Impact Studies for the Medical Education sector Contact us on: support@nuaxia.com

Geriatric medicine physicians in Japan reported a median annual income of ¥15 million (approximately £72,000) in the latest specialty-level physician income survey from the Physician Career Research Institute. The 2025 survey, based on responses from 2,055 physicians overall, provides a useful benchmark for geriatricians assessing their professional earnings in Japan. Among the Geriatric Medicine respondents: Median annual income: ¥15 million (approximately £72,000) Proportion earning ¥20 million or more: 21.74% ¥20 million threshold: approximately £96,000 Geriatric Medicine respondents: 23 Importantly, these figures include income from a geriatrician’s main workplace as well as additional or side work. For geriatricians looking at their own compensation, that distinction is essential. What is the median income for a geriatrician in Japan? The reported median annual income for geriatric medicine physicians was: ¥15 million (approximately £72,000) This represents total annual professional income including side work, rather than simply the salary paid by a geriatrician’s principal hospital, clinic or other employer. That matters because physicians in Japan may receive income from more than one professional role. A geriatrician may hold a primary position while also undertaking additional clinical sessions or other paid medical work. The ¥15 million figure is therefore best understood as a benchmark for total annual professional earnings. It should not be interpreted as an expected base salary. 21.74% of geriatricians reported earning ¥20 million or more The survey provides another useful benchmark for geriatric medicine physicians. 21.74% of Geriatric Medicine respondents reported annual income of ¥20 million or more (approximately £96,000+). That means just over one in five geriatricians included in the survey reported total annual professional earnings at or above this level. For a geriatrician assessing their own compensation, the two central figures are therefore: Median annual income: ¥15 million (approximately £72,000) Earning ¥20 million+ (approximately £96,000+): 21.74% Together, these figures provide a useful indication of the income levels reported within Geriatric Medicine. Why does side work matter for geriatrician income? Additional professional work can form an important part of physician earnings in Japan. Doctors may undertake paid work outside their main position, including sessions at other hospitals or clinics and other secondary medical activity. The Physician Career Research Institute therefore reports annual income including side work. For geriatricians, this means that salary from the principal employer may not represent total annual earnings. A geriatrician whose main salary is below ¥15 million could still reach or exceed the survey benchmark when supplementary professional income is included. Equally, the survey should not be interpreted as showing that geriatricians should expect a ¥15 million basic salary from a single employer. The figure represents a broader measure of total professional income. What does the ¥15 million median actually mean? There is an important methodological point behind the headline figure. Survey participants reported income in ranges rather than providing an exact annual amount. The reported median of ¥15 million (approximately £72,000) therefore represents the midpoint of the relevant income band. It should be treated as an approximate compensation benchmark rather than a precise mathematical median calculated from exact salary records. For a geriatrician reviewing their own income, the figure is most useful as a broad reference point for total annual professional earnings. How strong is the Geriatric Medicine sample? The wider survey included 2,055 physicians, with 23 respondents in Geriatric Medicine. That is an important limitation. The research only published specialty-level figures for groups with at least 15 respondents, so Geriatric Medicine met the threshold for inclusion. However, 23 physicians remain a relatively small sample. The findings should therefore be treated as a useful specialty benchmark rather than a definitive national estimate for every geriatrician working in Japan. Actual earnings may vary depending on factors such as: career stage; seniority; employer; hospital or clinic setting; working hours; geographic location; additional clinical commitments; and the amount of side work undertaken. Is ¥15 million a geriatrician salary? No. The clearest interpretation is: ¥15 million is the reported median total annual professional income for the geriatricians surveyed, including side work. It is not a published base salary. For a geriatrician considering a new role or assessing existing compensation, it can therefore be useful to distinguish between: guaranteed income from the principal employer; additional paid clinical sessions; other professional income; and total annual earnings. The survey benchmark relates most closely to that final figure. What should geriatricians take from the latest data? For geriatricians in Japan, the 2025 survey provides two particularly useful compensation benchmarks. Median annual professional income, including side work, was: ¥15 million (approximately £72,000) And: 21.74% of geriatricians reported earning ¥20 million or more (approximately £96,000+). For an individual geriatrician, these figures provide a useful reference point when considering total annual professional earnings. The important point is to compare like with like. A salary from a single hospital or clinic should not be compared directly with a survey figure that incorporates additional professional work. For geriatricians, the more useful question is therefore not simply: “What is a geriatrician’s salary in Japan?” It is: “What is my total annual professional income as a geriatrician, including additional clinical work, and how does it compare with the ¥15 million benchmark?” That is the most meaningful way to use the available Geriatric Medicine compensation data. Source: Physician Career Research Institute / Mediwel, 2025 Physician Income Survey. Currency note: Sterling equivalents are approximate conversions using the JPY/GBP exchange rate on 14 September 2026. At that rate, ¥15 million is approximately £72,000 and ¥20 million approximately £96,000. GBP figures are included for reader context only and were not reported by the original Japanese survey. Discover how nuaxia can support your next medical education initiative: Find out more about our specialist services - Moore's Outcome Assessments, Educational Needs Assessments and Patient Impact Studies for the Medical Education sector Contact us on: support@nuaxia.com

Radiologists in Japan reported a median annual income of ¥17 million (approximately £82,000) in the latest specialty-level physician income survey from the Physician Career Research Institute. The 2025 survey, based on responses from 2,055 physicians overall, provides a useful benchmark for radiologists assessing their professional earnings in Japan. Among the Radiology respondents: Median annual income: ¥17 million (approximately £82,000) Proportion earning ¥20 million or more: 22.64% ¥20 million threshold: approximately £96,000 Radiology respondents: 53 Importantly, these figures include income from a radiologist’s main workplace as well as additional or side work. For radiologists looking at their own compensation, that distinction is essential. What is the median income for a radiologist in Japan? The reported median annual income for radiologists was: ¥17 million (approximately £82,000) This represents total annual professional income including side work, rather than simply the salary paid by a radiologist’s principal hospital, clinic or other employer. That matters because physicians in Japan may receive income from more than one professional role. A radiologist may hold a primary hospital position while also undertaking additional reporting, clinical sessions or other paid medical work. The ¥17 million figure is therefore best understood as a benchmark for total annual professional earnings. It should not be interpreted as an expected base salary. 22.64% of radiologists reported earning ¥20 million or more The survey provides another useful benchmark for radiologists. 22.64% of Radiology respondents reported annual income of ¥20 million or more (approximately £96,000+). That means just under one in four radiologists included in the survey reported total annual professional earnings at or above this level. For a radiologist assessing their own compensation, the two central figures are therefore: Median annual income: ¥17 million (approximately £82,000) Earning ¥20 million+ (approximately £96,000+): 22.64% Together, these figures provide a useful indication of the income levels reported within Radiology. Why does side work matter for radiologist income? Additional professional work can form an important part of physician earnings in Japan. Doctors may undertake paid work outside their main position, including sessions at other hospitals or clinics and other secondary medical activity. The Physician Career Research Institute therefore reports annual income including side work. For radiologists, this means that salary from the principal employer may not represent total annual earnings. A radiologist whose main salary is below ¥17 million could still reach or exceed the survey benchmark once supplementary professional income is included. Equally, the survey should not be interpreted as showing that radiologists should expect a ¥17 million basic salary from a single employer. The figure represents a broader measure of total professional income. What does the ¥17 million median actually mean? There is an important methodological point behind the headline figure. Survey participants reported income in ranges rather than providing an exact annual amount. The reported median of ¥17 million (approximately £82,000) therefore represents the midpoint of the relevant income band. It should be treated as an approximate compensation benchmark rather than a precise mathematical median calculated from exact salary records. For a radiologist reviewing their own income, the figure is most useful as a broad reference point for total annual professional earnings. How strong is the Radiology sample? The wider survey included 2,055 physicians, with 53 respondents in Radiology. That gives radiology a useful specialty-specific sample within the research. However, it remains survey evidence rather than a national census of all radiologists working in Japan. Actual earnings may vary depending on factors such as: career stage; seniority; employer; hospital or imaging setting; working hours; geographic location; additional reporting or clinical commitments; and the amount of side work undertaken. For radiologists, the findings are therefore most useful as a current compensation benchmark rather than a guaranteed income level. Is ¥17 million a radiologist salary? No. The clearest interpretation is: ¥17 million is the reported median total annual professional income for the radiologists surveyed, including side work. It is not a published base salary. For a radiologist considering a new role or assessing existing compensation, it can therefore be useful to distinguish between: guaranteed income from the principal employer; additional paid reporting or clinical sessions; other professional income; and total annual earnings. The survey benchmark relates most closely to that final figure. What should radiologists take from the latest data? For radiologists in Japan, the 2025 survey provides two particularly useful compensation benchmarks. Median annual professional income, including side work, was: ¥17 million (approximately £82,000) And: 22.64% of radiologists reported earning ¥20 million or more (approximately £96,000+). For an individual radiologist, these figures provide a useful reference point when considering total annual professional earnings. The important point is to compare like with like. A salary from a single hospital or imaging provider should not be compared directly with a survey figure that incorporates additional professional work. For radiologists, the more useful question is therefore not simply: “What is a radiologist’s salary in Japan?” It is: “What is my total annual professional income as a radiologist, including additional clinical or reporting work, and how does it compare with the ¥17 million benchmark?” That is the most meaningful way to use the available Radiology compensation data. Source: Physician Career Research Institute / Mediwel, 2025 Physician Income Survey. Currency note: Sterling equivalents are approximate conversions using the JPY/GBP exchange rate on 14 September 2026. At that rate, ¥17 million is approximately £82,000 and ¥20 million approximately £96,000. GBP figures are included for reader context only and were not reported by the original Japanese survey. Discover how nuaxia can support your next medical education initiative: Find out more about our specialist services - Moore's Outcome Assessments, Educational Needs Assessments and Patient Impact Studies for the Medical Education sector Contact us on: support@nuaxia.com

The FDA has approved Telix's Pixclara as the first FET-PET imaging agent in the United States for evaluating glioma, providing a new tool to help distinguish tumour progression from treatment-related changes. Pixclara, or floretyrosine F 18, is a radioactive diagnostic imaging agent used with positron emission tomography to evaluate adults and paediatric patients with glioma. The approval addresses a significant diagnostic challenge in brain cancer care by providing amino-acid PET imaging that can help clinicians assess suspected recurrent or progressive disease when conventional imaging may be inconclusive. Field Content Alert Type Approval Drug Name Floretyrosine F 18 Brand Name Pixclara Company Telix Pharmaceuticals Regulatory Authority U.S. Food and Drug Administration Approval Type New diagnostic imaging drug approval Indication PET imaging of adults and paediatric patients with glioma Therapy Area(s) Oncology; neuro-oncology; diagnostic imaging Technology or Modality FET-PET; radioactive diagnostic imaging agent Geography United States What Happened The FDA approved Pixclara (floretyrosine F 18), Telix's FET-PET imaging agent for use in adults and paediatric patients with glioma. Why It Matters Pixclara is the first FDA-approved FET-PET imaging agent for glioma and provides clinicians with an additional tool for evaluating suspected recurrent or progressive brain cancer and distinguishing disease from treatment-related changes. Supporting Context Conventional MRI can have difficulty distinguishing recurrent tumour from treatment effects, creating a need for more specific molecular imaging approaches in glioma management. Key Takeaway Pixclara brings FDA-approved FET-PET imaging to the US for the first time, expanding diagnostic options for patients with glioma. What to Watch US commercial rollout, availability across PET imaging centres and integration of FET-PET into glioma diagnosis and follow-up pathways. Primary Source Telix Pharmaceuticals Relevant Date 14 September 2026 Discover how nuaxia can support your next medical education initiative: Find out more about our specialist services - Moore's Outcome Assessments, Educational Needs Assessments and Patient Impact Studies for the Medical Education sector Contact us on: support@nuaxia.com

Medicus Pharma has secured exclusive worldwide rights to Pfizer's CD228-targeted antibody-drug conjugate PF-08046031 in an oncology licensing agreement potentially worth more than $1 billion. Medicus will pay Pfizer $12 million upfront and a further $15 million after one year, with Pfizer eligible for more than $1 billion in development, regulatory and commercial milestone payments plus royalties on future sales. The transaction adds a potentially first-in-class CD228-targeted antibody-drug conjugate to Medicus' oncology pipeline and gives the company responsibility for its future development and commercialisation worldwide. Field Content Alert Type Deal Companies Medicus Pharma; Pfizer Deal Type Exclusive worldwide licensing agreement Asset or Company PF-08046031 / CD228V Therapy Area(s) Oncology; solid tumours Technology or Modality CD228-targeted antibody-drug conjugate Deal Value US$12 million upfront, US$15 million after one year, more than US$1 billion in potential development, regulatory and commercial milestones, plus royalties Geography Worldwide What Happened Medicus Pharma secured exclusive worldwide rights from Pfizer to develop and commercialise the CD228-targeted antibody-drug conjugate PF-08046031, also known as CD228V. Why It Matters The agreement gives Medicus control of a potentially differentiated oncology asset targeting CD228 and represents a substantial expansion of the company's therapeutic pipeline. Supporting Context PF-08046031 is an early-stage antibody-drug conjugate designed to target CD228, a cell-surface protein expressed across several tumour types. Strategic Rationale Medicus gains a global oncology development asset while Pfizer retains substantial economic participation through milestone payments and royalties. Potential Impact Successful development could establish a new targeted treatment approach for cancers expressing CD228 and materially broaden Medicus' oncology portfolio. Key Takeaway Medicus Pharma has licensed Pfizer's CD228V antibody-drug conjugate globally in a transaction carrying more than US$1 billion in potential milestone payments. What to Watch Medicus' development plans for PF-08046031, progression into further clinical evaluation and selection of priority tumour indications. Primary Source U.S. Securities and Exchange Commission Relevant Date 11 September 2026 Discover how nuaxia can support your next medical education initiative: Find out more about our specialist services - Moore's Outcome Assessments, Educational Needs Assessments and Patient Impact Studies for the Medical Education sector Contact us on: support@nuaxia.com

The FDA has approved Isembyld as the first spinal muscular atrophy treatment designed to directly target muscle loss, for patients aged 2 years and older receiving an SMN2-targeted therapy. Isembyld, also known as apitegromab-mstn, is a muscle-targeted monoclonal antibody that inhibits myostatin activation and is used alongside existing SMN2-targeted treatment for spinal muscular atrophy. The approval introduces a complementary treatment approach that acts directly on skeletal muscle rather than the underlying SMN pathway, providing a new option for eligible children and adults with SMA. Field Content Alert Type Approval Drug Name Apitegromab-mstn Brand Name Isembyld Company Scholar Rock Regulatory Authority U.S. Food and Drug Administration Approval Type New drug approval Indication Treatment of spinal muscular atrophy in adults and paediatric patients aged 2 years and older receiving an SMN2-targeted therapy Therapy Area(s) Neurology; rare disease; neuromuscular disease Technology or Modality Monoclonal antibody; myostatin inhibitor Geography United States What Happened The FDA approved Isembyld (apitegromab-mstn) for adults and children aged 2 years and older with spinal muscular atrophy who are receiving an SMN2-targeted treatment. Why It Matters Isembyld is the first approved SMA treatment designed to directly target muscle loss, providing a complementary mechanism to existing therapies that act on the underlying SMN pathway. Supporting Context Apitegromab-mstn is a monoclonal antibody designed to selectively inhibit activation of myostatin, a negative regulator of skeletal muscle growth. Key Takeaway Isembyld introduces the first FDA-approved muscle-targeted treatment for eligible patients with spinal muscular atrophy. What to Watch Clinical uptake alongside SMN2-targeted therapies and longer-term evidence on motor function and treatment outcomes across SMA populations. Primary Source U.S. Food and Drug Administration Relevant Date 11 September 2026 Discover how nuaxia can support your next medical education initiative: Find out more about our specialist services - Moore's Outcome Assessments, Educational Needs Assessments and Patient Impact Studies for the Medical Education sector Contact us on: support@nuaxia.com

Neurologists in Japan reported a median annual income of ¥17 million (approximately £82,000) in the latest specialty-level physician income survey from the Physician Career Research Institute. The 2025 survey, based on responses from 2,055 physicians overall, provides a useful benchmark for neurologists assessing their professional earnings in Japan. Among the Neurology respondents: Median annual income: ¥17 million (approximately £82,000) Proportion earning ¥20 million or more: 25.64% ¥20 million threshold: approximately £96,000 Neurology respondents: 39 Importantly, these figures include income from a neurologist’s main workplace as well as additional or side work. For neurologists looking at their own compensation, that distinction is essential. What is the median income for a neurologist in Japan? The reported median annual income for neurologists was: ¥17 million (approximately £82,000) This represents total annual professional income including side work, rather than simply the salary paid by a neurologist’s principal hospital, clinic or other employer. That matters because physicians in Japan may receive income from more than one professional role. A neurologist may hold a primary hospital or clinic position while also undertaking additional clinical sessions or other paid medical work. The ¥17 million figure is therefore best understood as a benchmark for total annual professional earnings. It should not be interpreted as an expected base salary. 25.64% of neurologists reported earning ¥20 million or more The survey provides another useful benchmark for neurologists. 25.64% of Neurology respondents reported annual income of ¥20 million or more (approximately £96,000+). That means around one in four neurologists included in the survey reported total annual professional earnings at or above this level. For a neurologist assessing their own compensation, the two central figures are therefore: Median annual income: ¥17 million (approximately £82,000) Earning ¥20 million+ (approximately £96,000+): 25.64% Together, these figures provide a useful indication of the income levels reported within Neurology. Why does side work matter for neurologist income? Additional professional work can form an important part of physician earnings in Japan. Doctors may undertake paid work outside their main position, including sessions at other hospitals or clinics and other secondary medical activity. The Physician Career Research Institute therefore reports annual income including side work. For neurologists, this means that salary from the principal employer may not represent total annual earnings. A neurologist whose main salary is below ¥17 million could still reach or exceed the survey benchmark when supplementary clinical income is included. Equally, the survey should not be interpreted as showing that neurologists should expect a ¥17 million basic salary from a single employer. The figure represents a broader measure of total professional income. What does the ¥17 million median actually mean? There is an important methodological point behind the headline figure. Survey participants reported income in ranges rather than providing an exact annual amount. The reported median of ¥17 million (approximately £82,000) therefore represents the midpoint of the relevant income band. It should be treated as an approximate compensation benchmark rather than a precise mathematical median calculated from exact salary records. For a neurologist reviewing their own income, the figure is most useful as a broad reference point for total annual professional earnings. How strong is the Neurology sample? The wider survey included 2,055 physicians, with 39 respondents in Neurology. That gives neurology its own identifiable specialty sample within the research. However, it remains survey evidence rather than a national census of all neurologists working in Japan. Actual earnings may vary depending on factors such as: career stage; seniority; employer; hospital or clinic setting; working hours; geographic location; additional clinical commitments; and the amount of side work undertaken. For neurologists, the findings are therefore most useful as a current compensation benchmark rather than a guaranteed income level. Is ¥17 million a neurologist salary? No. The clearest interpretation is: ¥17 million is the reported median total annual professional income for the neurologists surveyed, including side work. It is not a published base salary. For a neurologist considering a new role or assessing existing compensation, it can therefore be useful to distinguish between: guaranteed income from the principal employer; additional paid clinical sessions; other professional income; and total annual earnings. The survey benchmark relates most closely to that final figure. What should neurologists take from the latest data? For neurologists in Japan, the 2025 survey provides two particularly useful compensation benchmarks. Median annual professional income, including side work, was: ¥17 million (approximately £82,000) And: 25.64% of neurologists reported earning ¥20 million or more (approximately £96,000+). For an individual neurologist, these figures provide a useful reference point when considering total annual professional earnings. The important point is to compare like with like. A salary from a single hospital or clinic should not be compared directly with a survey figure that incorporates additional professional work. For neurologists, the more useful question is therefore not simply: “What is a neurologist’s salary in Japan?” It is: “What is my total annual professional income as a neurologist, including additional clinical work, and how does it compare with the ¥17 million benchmark?” That is the most meaningful way to use the available Neurology compensation data. Source: Physician Career Research Institute / Mediwel, 2025 Physician Income Survey. Currency note: Sterling equivalents are approximate conversions using the JPY/GBP exchange rate on 14 September 2026. At that rate, ¥17 million is approximately £82,000 and ¥20 million approximately £96,000. GBP figures are included for reader context only and were not reported by the original Japanese survey. Discover how nuaxia can support your next medical education initiative: Find out more about our specialist services - Moore's Outcome Assessments, Educational Needs Assessments and Patient Impact Studies for the Medical Education sector Contact us on: support@nuaxia.com

Dermatologists in Japan reported a median annual income of ¥15 million (approximately £72,000) in the latest specialty-level physician income survey from the Physician Career Research Institute. The 2025 survey, based on responses from 2,055 physicians overall, provides a useful benchmark for dermatologists assessing their professional earnings in Japan. Among the Dermatology respondents: Median annual income: ¥15 million (approximately £72,000) Proportion earning ¥20 million or more: 26.67% ¥20 million threshold: approximately £96,000 Dermatology respondents: 60 Importantly, these figures include income from a dermatologist’s main workplace as well as additional or side work. For dermatologists looking at their own compensation, that distinction is essential. What is the median income for a dermatologist in Japan? The reported median annual income for dermatologists was: ¥15 million (approximately £72,000) This represents total annual professional income including side work, rather than simply the salary paid by a dermatologist’s principal hospital, clinic or other employer. That matters because physicians in Japan may receive income from more than one professional role. A dermatologist may hold a primary position while also undertaking additional clinical sessions or other paid medical work. The ¥15 million figure is therefore best understood as a benchmark for total annual professional earnings. It should not be interpreted as an expected base salary. 26.67% of dermatologists reported earning ¥20 million or more The survey provides another useful benchmark for dermatologists. 26.67% of Dermatology respondents reported annual income of ¥20 million or more (approximately £96,000+). That means just over one in four dermatologists included in the survey reported total annual professional earnings at or above this level. For a dermatologist assessing their own compensation, the two central figures are therefore: Median annual income: ¥15 million (approximately £72,000) Earning ¥20 million+ (approximately £96,000+): 26.67% Together, these figures provide a useful indication of the income levels reported within Dermatology. Why does side work matter for dermatologist income? Additional professional work can form an important part of physician earnings in Japan. Doctors may undertake paid work outside their main position, including sessions at other hospitals or clinics and other secondary medical activity. The Physician Career Research Institute therefore reports annual income including side work. For dermatologists, this means that salary from the principal employer may not represent total annual earnings. A dermatologist whose main salary is below ¥15 million could still reach or exceed the survey benchmark when supplementary clinical income is included. Equally, the survey should not be interpreted as showing that dermatologists should expect a ¥15 million basic salary from a single employer. The figure represents a broader measure of total professional income. What does the ¥15 million median actually mean? There is an important methodological point behind the headline figure. Survey participants reported income in ranges rather than providing an exact annual amount. The reported median of ¥15 million (approximately £72,000) therefore represents the midpoint of the relevant income band. It should be treated as an approximate compensation benchmark rather than a precise mathematical median calculated from exact salary records. For a dermatologist reviewing their own income, the figure is most useful as a broad reference point for total annual professional earnings. How strong is the Dermatology sample? The wider survey included 2,055 physicians, with 60 respondents in Dermatology. That gives dermatology a useful specialty-specific sample within the research. However, it remains survey evidence rather than a national census of all dermatologists working in Japan. Actual earnings may vary depending on factors such as: career stage; seniority; employer; hospital or clinic setting; working hours; geographic location; additional clinical commitments; and the amount of side work undertaken. For dermatologists, the findings are therefore most useful as a current compensation benchmark rather than a guaranteed income level. Is ¥15 million a dermatologist salary? No. The clearest interpretation is: ¥15 million is the reported median total annual professional income for the dermatologists surveyed, including side work. It is not a published base salary. For a dermatologist considering a new role or assessing existing compensation, it can therefore be useful to distinguish between: guaranteed income from the principal employer; additional paid clinical sessions; other professional income; and total annual earnings. The survey benchmark relates most closely to that final figure. What should dermatologists take from the latest data? For dermatologists in Japan, the 2025 survey provides two particularly useful compensation benchmarks. Median annual professional income, including side work, was: ¥15 million (approximately £72,000) And: 26.67% of dermatologists reported earning ¥20 million or more (approximately £96,000+). For an individual dermatologist, these figures provide a useful reference point when considering total annual professional earnings. The important point is to compare like with like. A salary from a single hospital or clinic should not be compared directly with a survey figure that incorporates additional professional work. For dermatologists, the more useful question is therefore not simply: “What is a dermatologist’s salary in Japan?” It is: “What is my total annual professional income as a dermatologist, including additional clinical work, and how does it compare with the ¥15 million benchmark?” That is the most meaningful way to use the available Dermatology compensation data. Source: Physician Career Research Institute / Mediwel, 2025 Physician Income Survey. Currency note: Sterling equivalents are approximate conversions using a JPY/GBP rate of roughly £0.0048 per yen on 14 September 2026. On that basis, ¥15 million is approximately £72,000 and ¥20 million approximately £96,000. GBP figures are included for reader context only and were not reported by the original Japanese survey. Discover how nuaxia can support your next medical education initiative: Find out more about our specialist services - Moore's Outcome Assessments, Educational Needs Assessments and Patient Impact Studies for the Medical Education sector Contact us on: support@nuaxia.com

Plastic surgeons in Japan reported a median annual income of ¥16 million (approximately £77,000) in the latest specialty-level physician income survey from the Physician Career Research Institute. The 2025 survey, based on responses from 2,055 physicians overall, provides a useful benchmark for plastic surgeons assessing their professional earnings in Japan. Among the Plastic Surgery respondents: Median annual income: ¥16 million (approximately £77,000) Proportion earning ¥20 million or more: 27.78% ¥20 million threshold: approximately £96,000 Plastic Surgery respondents: 36 Importantly, these figures include income from a plastic surgeon’s main workplace as well as additional or side work. For plastic surgeons looking at their own compensation, that distinction is essential. What is the median income for a plastic surgeon in Japan? The reported median annual income for plastic surgeons was: ¥16 million (approximately £77,000) This represents total annual professional income including side work, rather than simply the salary paid by a plastic surgeon’s principal hospital, clinic or other employer. That matters because physicians in Japan may receive income from more than one professional role. A plastic surgeon may hold a primary position while also undertaking additional clinical sessions or other paid medical work. The ¥16 million figure is therefore best understood as a benchmark for total annual professional earnings. It should not be interpreted as an expected base salary. 27.78% of plastic surgeons reported earning ¥20 million or more The survey provides another useful benchmark for plastic surgeons. 27.78% of Plastic Surgery respondents reported annual income of ¥20 million or more (approximately £96,000+). That means more than one in four plastic surgeons included in the survey reported total annual professional earnings at or above this level. For a plastic surgeon assessing their own compensation, the two central figures are therefore: Median annual income: ¥16 million (approximately £77,000) Earning ¥20 million+ (approximately £96,000+): 27.78% Together, these figures provide a useful indication of the income levels reported within Plastic Surgery. Why does side work matter for plastic surgeon income? Additional professional work can form an important part of physician earnings in Japan. Doctors may undertake paid work outside their principal position, including sessions at other hospitals or clinics and other secondary medical activity. The Physician Career Research Institute therefore reports annual income including side work. For plastic surgeons, this means that salary from the main employer may not represent total annual earnings. A plastic surgeon whose principal salary is below ¥16 million could still reach or exceed the survey benchmark once supplementary professional income is included. Equally, the survey should not be interpreted as showing that plastic surgeons should expect a ¥16 million basic salary from a single employer. The figure represents a broader measure of total professional income. What does the ¥16 million median actually mean? There is an important methodological point behind the headline figure. Survey participants reported income in ranges rather than providing an exact annual amount. The reported median of ¥16 million (approximately £77,000) therefore represents the midpoint of the relevant income band used by the survey. It should be treated as an approximate compensation benchmark rather than a precise mathematical median calculated from exact salary records. For a plastic surgeon reviewing their own income, the figure is most useful as a broad reference point for total annual professional earnings. How strong is the Plastic Surgery sample? The wider survey included 2,055 physicians, with 36 respondents in Plastic Surgery. That gives the specialty its own identifiable sample within the research. However, 36 respondents is still a relatively small group, so the findings should not be treated as a definitive national estimate for every plastic surgeon working in Japan. Actual earnings may vary depending on factors such as: career stage; seniority; employer; hospital or clinic setting; working hours; geographic location; additional clinical commitments; and the amount of side work undertaken. For plastic surgeons, the findings are therefore most useful as a current compensation benchmark rather than a guaranteed income level. Is ¥16 million a plastic surgeon salary? No. The clearest interpretation is: ¥16 million is the reported median total annual professional income for the plastic surgeons surveyed, including side work. It is not a published base salary. For a plastic surgeon considering a new role or assessing existing compensation, it can therefore be useful to distinguish between: guaranteed income from the principal employer; additional paid clinical sessions; other professional income; and total annual earnings. The survey benchmark relates most closely to that final figure. What should plastic surgeons take from the latest data? For plastic surgeons in Japan, the 2025 survey provides two particularly useful compensation benchmarks. Median annual professional income, including side work, was: ¥16 million (approximately £77,000) And: 27.78% of plastic surgeons reported earning ¥20 million or more (approximately £96,000+). For an individual plastic surgeon, these figures provide a useful reference point when considering total annual professional earnings. The important point is to compare like with like. A salary from a single hospital or clinic should not be compared directly with a survey figure that incorporates additional professional work. For plastic surgeons, the more useful question is therefore not simply: “What is a plastic surgeon’s salary in Japan?” It is: “What is my total annual professional income as a plastic surgeon, including additional clinical work, and how does it compare with the ¥16 million benchmark?” That is the most meaningful way to use the available Plastic Surgery compensation data. Source: Physician Career Research Institute / Mediwel, 2025 Physician Income Survey. Currency note: Sterling equivalents are approximate conversions using a JPY/GBP rate of roughly £0.0048 per yen on 14 September 2026. On that basis, ¥16 million is approximately £77,000 and ¥20 million approximately £96,000. GBP figures are included for reader context only and were not reported by the original Japanese survey. Discover how nuaxia can support your next medical education initiative: Find out more about our specialist services - Moore's Outcome Assessments, Educational Needs Assessments and Patient Impact Studies for the Medical Education sector Contact us on: support@nuaxia.com